Cross-source evidence timeline
Lanreotide research timeline
Follow 68 selected, directly cited source records from August 30, 2007 through June 27, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
PubMed record PMID 41880072↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41880072 at 2026-07-30T16:14:14.928Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-03-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 39933708↗
PeptideScanner retained PubMed bibliographic metadata for PMID 39933708 at 2026-07-30T16:14:10.854Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-02-11. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 38071418↗
PeptideScanner retained PubMed bibliographic metadata for PMID 38071418 at 2026-07-30T16:20:36.586Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2023-12-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
β-Cyclodextrin derivatives bind aromatic side chains of the cyclic peptide lanreotide.↗
PubMed lists PMID 39491674 in Journal of pharmaceutical sciences as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-11-02 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 2, 2024 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.↗
PubMed lists PMID 38206830 in The oncologist as Journal Article, Clinical Trial, Phase II, Research Support, Non-U.S. Gov't, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2024-05-03 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 3, 2024 · day precisionAdded to PeptideScanner August 13, 2026Safety
FDA enforcement report D-0422-2026↗
FDA's dated enforcement report D-0422-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.↗
Added to PeptideScanner August 25, 2026Safety
FDA enforcement report D-0423-2026↗
FDA's dated enforcement report D-0423-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application ANDA217193 through exact openFDA application-number annotations.↗
Added to PeptideScanner August 25, 2026Clinical trials
ClinicalTrials.gov record NCT05048901↗
PeptideScanner retained ClinicalTrials.gov record NCT05048901 at 2026-07-30T16:20:49.324Z. Its registry update date was 2026-04-09, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 8, 2026Clinical trials
ClinicalTrials.gov record NCT02127437↗
PeptideScanner retained ClinicalTrials.gov record NCT02127437 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 8, 2026Clinical trials
ClinicalTrials.gov record NCT06807437↗
PeptideScanner retained ClinicalTrials.gov record NCT06807437 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026Literature metadata
Lanreotide in endothelial corneal inflammation.↗
PubMed lists PMID 41071230 in Hormones (Athens, Greece) as Letter, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 10, 2025 · day precisionAdded to PeptideScanner August 13, 2026Clinical trials
ClinicalTrials.gov record NCT03946527↗
PeptideScanner retained ClinicalTrials.gov record NCT03946527 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026Literature metadata
Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel).↗
PubMed lists PMID 15789272 in Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association as Journal Article, with publication-date metadata of 2005-03 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 2005 · month precisionAdded to PeptideScanner August 14, 2026Safety
FDA enforcement report D-0290-2026↗
FDA's dated enforcement report D-0290-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.↗
Added to PeptideScanner August 25, 2026
Source year
2025
Regulatory
Lanreotide DailyMed SPL version 3↗
DailyMed lists Structured Product Labeling version 3 for the reviewed Lanreotide label family with a published date of 2025-06-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026
Source year
2024
Regulatory
Lanreotide DailyMed SPL version 2↗
DailyMed lists Structured Product Labeling version 2 for the reviewed Lanreotide label family with a published date of 2024-12-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Lanreotide DailyMed SPL version 1↗
DailyMed lists Structured Product Labeling version 1 for the reviewed Lanreotide label family with a published date of 2024-05-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Drugs@FDA application ANDA217193↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 217193 with status AP dated 2024-05-21, and names lanreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026
Source year
2023
Clinical trials
ClinicalTrials.gov record NCT03043664↗
PeptideScanner retained ClinicalTrials.gov record NCT03043664 at 2026-07-30T19:11:49.726Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2022
Clinical trials
ClinicalTrials.gov record NCT00774930↗
PeptideScanner retained ClinicalTrials.gov record NCT00774930 at 2026-07-30T19:34:18.792Z. Its registry update date was 2022-10-14, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT03158090↗
PeptideScanner retained ClinicalTrials.gov record NCT03158090 at 2026-07-30T19:42:14.203Z. Its registry update date was 2022-03-16, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2021
Regulatory
Drugs@FDA application NDA215395↗
The official Drugs@FDA dataset lists original submission 1 for NDA 215395 with status AP dated 2021-12-17, and names lanreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT03012594↗
PeptideScanner retained ClinicalTrials.gov record NCT03012594 at 2026-07-30T20:07:13.495Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2019
Clinical trials
ClinicalTrials.gov record NCT02075606↗
PeptideScanner retained ClinicalTrials.gov record NCT02075606 at 2026-07-30T20:50:35.870Z. Its registry update date was 2019-06-07, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2017
Clinical trials
ClinicalTrials.gov record NCT02351128↗
PeptideScanner retained ClinicalTrials.gov record NCT02351128 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-10-18, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2016
Literature metadata
[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog].↗
PubMed lists PMID 8099735 in Presse medicale (Paris, France : 1983) as Journal Article, with publication-date metadata of 1993-03-27 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 27, 1993 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma.↗
PubMed lists PMID 25746137 in Clinics and research in hepatology and gastroenterology as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03-04 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 4, 2015 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Long-acting lanreotide in adolescent girls with constitutional tall stature.↗
PubMed lists PMID 19258715 in Hormone research as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2009-03-04 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 4, 2009 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.↗
PubMed lists PMID 20168286 in The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... as Clinical Trial, Journal Article, with publication-date metadata of 2010-02 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 2010 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Elucidation of the self-assembly pathway of lanreotide octapeptide into beta-sheet nanotubes: role of two stable intermediates.↗
PubMed lists PMID 20199027 in Journal of the American Chemical Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-03-31 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 31, 2010 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.↗
PubMed lists PMID 20604834 in The Journal of pharmacy and pharmacology as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 2010 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Use of lanreotide for the treatment of gastrointestinal fistulae.↗
PubMed lists PMID 21135689 in Annals of surgery as Letter, Comment, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 2011 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Resolving bile reflux by lanreotide in patients with Roux-en-Y gastrojejunostomy.↗
PubMed lists PMID 25682623 in Acta gastro-enterologica Belgica as Case Reports, Journal Article, with publication-date metadata of 2014-12 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2014 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Somatuline(R) Autogel(R), a new formulation of lanreotide for the treatment of acromegalic patients].↗
PubMed lists PMID 12037499 in Annales d'endocrinologie as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2002-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 2002 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Lanreotide in the treatment of thyroid orbitopathy].↗
PubMed lists PMID 15789913 in Przeglad lekarski as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2004 · year precisionAdded to PeptideScanner August 13, 2026Literature metadata
Pharmacokinetics and population pharmacodynamic analysis of lanreotide Autogel.↗
PubMed lists PMID 16154424 in Metabolism: clinical and experimental as Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 2005 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide.↗
PubMed lists PMID 17854356 in The British journal of dermatology as Case Reports, Letter, with publication-date metadata of 2007-09-13 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 13, 2007 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Self-assembly of the octapeptide lanreotide and lanreotide-based derivatives: the role of the aromatic residues.↗
PubMed lists PMID 17929329 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 2008 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Optimalization and cost management of lanreotide-Autogel therapy in acromegaly.↗
PubMed lists PMID 17984236 in European journal of endocrinology as Comparative Study, Journal Article, Multicenter Study, with publication-date metadata of 2007-11 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 2007 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Lanreotide autogel and insulin sensitivity markers: report of 5 acromegalic patients and literature review.↗
PubMed lists PMID 18063933 in Neuro endocrinology letters as Clinical Trial, Journal Article, Review, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2007 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Lanreotide Autogel for persistent diabetic macular edema.↗
PubMed lists PMID 18367285 in Diabetes research and clinical practice as Case Reports, Journal Article, with publication-date metadata of 2008-03-26 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 26, 2008 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide).↗
PubMed lists PMID 18684551 in European journal of obstetrics, gynecology, and reproductive biology as Case Reports, Letter, with publication-date metadata of 2008-08-05 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 5, 2008 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
PubMed record PMID 10199803↗
PeptideScanner retained PubMed bibliographic metadata for PMID 10199803 at 2026-07-30T21:35:52.336Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-04-13. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 10231313↗
PeptideScanner retained PubMed bibliographic metadata for PMID 10231313 at 2026-07-30T21:35:52.337Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-05-07. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 10480146↗
PeptideScanner retained PubMed bibliographic metadata for PMID 10480146 at 2026-07-30T21:35:52.338Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-09-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 10579475↗
PeptideScanner retained PubMed bibliographic metadata for PMID 10579475 at 2026-07-30T21:35:52.340Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-12-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 10748802↗
PeptideScanner retained PubMed bibliographic metadata for PMID 10748802 at 2026-07-30T21:35:52.342Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-04-05. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 11095353↗
PeptideScanner retained PubMed bibliographic metadata for PMID 11095353 at 2026-07-30T21:35:52.345Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-11-30. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 11128563↗
PeptideScanner retained PubMed bibliographic metadata for PMID 11128563 at 2026-07-30T21:35:52.346Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-12-29. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 8954072↗
PeptideScanner retained PubMed bibliographic metadata for PMID 8954072 at 2026-07-30T21:35:51.206Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1996-12-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 9119171↗
PeptideScanner retained PubMed bibliographic metadata for PMID 9119171 at 2026-07-30T21:35:52.319Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1996-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 9537429↗
PeptideScanner retained PubMed bibliographic metadata for PMID 9537429 at 2026-07-30T21:35:52.324Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1998-04-16. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 9867148↗
PeptideScanner retained PubMed bibliographic metadata for PMID 9867148 at 2026-07-30T21:35:52.335Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1998-12-29. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 9934776↗
PeptideScanner retained PubMed bibliographic metadata for PMID 9934776 at 2026-07-30T21:35:52.335Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-02-06. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 8975096↗
PeptideScanner retained PubMed bibliographic metadata for PMID 8975096 at 2026-07-30T21:35:51.206Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-09-07. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 7864583↗
PeptideScanner retained PubMed bibliographic metadata for PMID 7864583 at 2026-07-30T21:35:51.193Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1994-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 8646723↗
PeptideScanner retained PubMed bibliographic metadata for PMID 8646723 at 2026-07-30T21:35:51.201Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-07-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 8786564↗
PeptideScanner retained PubMed bibliographic metadata for PMID 8786564 at 2026-07-30T21:35:51.203Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-03-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 8931985↗
PeptideScanner retained PubMed bibliographic metadata for PMID 8931985 at 2026-07-30T21:35:51.205Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-09-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 7540120↗
PeptideScanner retained PubMed bibliographic metadata for PMID 7540120 at 2026-07-30T21:35:51.187Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 27200668↗
PeptideScanner retained PubMed bibliographic metadata for PMID 27200668 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026
Source year
2014
Literature metadata
PubMed record PMID 15003204↗
PeptideScanner retained PubMed bibliographic metadata for PMID 15003204 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-08-18 and an Entrez history date of 2004-03-09. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Regulatory
Federal Register notice 2014-17293↗
The Federal Register published notice 2014-17293, attributed to FDA and its parent HHS department, on 2014-07-23. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.↗
Added to PeptideScanner August 21, 2026Clinical trials
ClinicalTrials.gov record NCT01354405↗
PeptideScanner retained ClinicalTrials.gov record NCT01354405 at 2026-07-30T21:54:46.540Z. Its registry update date was 2014-07-09, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2011
Literature metadata
PubMed record PMID 21607321↗
PeptideScanner retained PubMed bibliographic metadata for PMID 21607321 at 2026-07-30T22:17:00.088Z. PubMed recorded a metadata revision date of 2011-05-24 and an Entrez history date of 2011-05-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026
Source year
2009
Clinical trials
ClinicalTrials.gov record NCT00565097↗
PeptideScanner retained ClinicalTrials.gov record NCT00565097 at 2026-07-30T22:26:45.013Z. Its registry update date was 2009-02-17, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2008
Regulatory
Federal Register notice E8-27179↗
The Federal Register published notice E8-27179, attributed to FDA and its parent HHS department, on 2008-11-17. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.↗
Added to PeptideScanner August 21, 2026
Source year
2007
Regulatory
Drugs@FDA application NDA022074↗
The official Drugs@FDA dataset lists original submission 1 for NDA 022074 with status AP dated 2007-08-30, and names lanreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026